Professor Richard Green (1944–2020) was a British neuropharmacologist.
Professor Richard Green | |
|---|---|
| Born | 1944 (age 79–80) |
| Died | Sept 2020 |
| Nationality | United Kingdom |
Green obtained his PhD in 1969 under the supervision of Gerald Curzon, and then spent two years at the National Institute of Mental Health in Washington, D.C.[1]
He then obtained a position at the Medical Research Council's clinical pharmacology unit in Oxford, rising to become its assistant unit director in 1981.[1]
He took up the role of director of the Astra Neuroscience Research Unit in 1986. Ten years later he became director of the Global Discovery CNS & Pain Control, for Astra.[1]
Upon formal retirement in 2007 he undertook psychopharmacology research as honorary professor of neuropharmacology at the University of Nottingham.[1]
He was given his DSc by London University in 1988 and the British Association for Psychopharmacology's Lifetime Achievement Award in 2010.[1]
He was a president emeritus of the British Pharmacological Society, and was elected an Honorary Fellow by them in 2013, and was a former president of the Serotonin Club.[1][2]
References
edit- ^ a b c d e f Caroline Overy; Tilli Tansey, eds. (2013). Drugs Affecting 5-HT Systems. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-902238-87-9. Wikidata Q29581800.
- ^ "Professor Richard Green PhD DSc". British Pharmacological Society. Retrieved 3 August 2017.
External links
edit- Richard Green on the History of Modern Biomedicine Research Group website
 | This United Kingdom biographical article related to medicine is a stub. You can help Wikipedia by expanding it. |